{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/49337"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/49337","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"Optimization of adeno-associated virus production for misexpression of Dlk1-Dio3 noncoding RNAs in cardiac and skeletal muscle analysis in vivo","abstract":"Efficient targeting of genes to either inhibit or increase their expression in specific tissues in vivo remains a challenge. Adeno-Associated Virus (AAV) has emerged as an efficacious delivery method in both humans and murine model systems. AAV is a non-enveloped, single-stranded DNA virus that is non-integrating with long-term expression. Due to its low immunogenicity and various serotypes with specific tissue tropisms, AAV is a preferred choice for organ specific-gene delivery in many experimental settings. This project focused on protocol optimization for high-volume production of AAV plasmids, improved transfection efficiency, and increased viral yield and purity to specifically target noncoding RNAs (ncRNAs) expressed from the imprinted Dlk1-Dio3 locus. Five AAV9 viruses were produced, each containing one of the following transgenes: 1) human Meg3 cDNA for overexpression of this long noncoding RNA, 2) Meg3-specific short hairpin RNA for knockdown analysis, 3) eGFP cDNA to demonstrate AAV9 tissue tropism, 4) Cas9 cDNA, and 5) gene-specific guide RNAs to target the Meg3 proximal promoter. The AAV9 virus production protocol optimized in this project expands the tools available for in vivo study of the Dlk1-Dio3 ncRNA locus.","abstract_html":"Efficient targeting of genes to either inhibit or increase their expression in specific tissues in vivo remains a challenge. Adeno-Associated Virus (AAV) has emerged as an efficacious delivery method in both humans and murine model systems. AAV is a non-enveloped, single-stranded DNA virus that is non-integrating with long-term expression. Due to its low immunogenicity and various serotypes with specific tissue tropisms, AAV is a preferred choice for organ specific-gene delivery in many experimental settings. This project focused on protocol optimization for high-volume production of AAV plasmids, improved transfection efficiency, and increased viral yield and purity to specifically target noncoding RNAs (ncRNAs) expressed from the imprinted Dlk1-Dio3 locus. Five AAV9 viruses were produced, each containing one of the following transgenes: 1) human Meg3 cDNA for overexpression of this long noncoding RNA, 2) Meg3-specific short hairpin RNA for knockdown analysis, 3) eGFP cDNA to demonstrate AAV9 tissue tropism, 4) Cas9 cDNA, and 5) gene-specific guide RNAs to target the Meg3 proximal promoter. The AAV9 virus production protocol optimized in this project expands the tools available for in vivo study of the Dlk1-Dio3 ncRNA locus.","abstract_has_math":false,"creators":["Sutton, Hannah Marie"],"institution":"Boston University","degree_name":"M.A.","degree_level":"masters","degree_discipline":"Molecular Biology, Cell Biology & Biochemistry","degree_department":null,"school":null,"contributors":[],"advisors":["Naya, Francisco J."],"committee_chairs":[],"committee_members":[],"year":2023,"date_issued":"2023","date_published":"2023","updated_at":"2026-11-18T19:53:16Z","subjects":["Molecular biology","Adeno-associated virus","Dlk1-Dio3 locus","Meg3","Noncoding RNA"],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/2144/49337","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/49337","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F49337","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Naya, Francisco J."]},{"key":"dc:creator","label":"Author","values":["Sutton, Hannah Marie"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2024-09-26T14:56:31Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2024-09-26T14:56:31Z"]},{"key":"dc:date.issued","label":"Date","values":["2023"]},{"key":"dc:date.updated","label":"Dc Date Updated","values":["2024-09-25T19:02:19Z"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Molecular Biology, Cell Biology & Biochemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["masters"]},{"key":"thesis:degree_name","label":"Degree Name","values":["M.A."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Molecular biology","Adeno-associated virus","Dlk1-Dio3 locus","Meg3","Noncoding RNA"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/49337"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Efficient targeting of genes to either inhibit or increase their expression in specific tissues in vivo remains a challenge. Adeno-Associated Virus (AAV) has emerged as an efficacious delivery method in both humans and murine model systems. AAV is a non-enveloped, single-stranded DNA virus that is non-integrating with long-term expression. Due to its low immunogenicity and various serotypes with specific tissue tropisms, AAV is a preferred choice for organ specific-gene delivery in many experimental settings. This project focused on protocol optimization for high-volume production of AAV plasmids, improved transfection efficiency, and increased viral yield and purity to specifically target noncoding RNAs (ncRNAs) expressed from the imprinted Dlk1-Dio3 locus. Five AAV9 viruses were produced, each containing one of the following transgenes: 1) human Meg3 cDNA for overexpression of this long noncoding RNA, 2) Meg3-specific short hairpin RNA for knockdown analysis, 3) eGFP cDNA to demonstrate AAV9 tissue tropism, 4) Cas9 cDNA, and 5) gene-specific guide RNAs to target the Meg3 proximal promoter. The AAV9 virus production protocol optimized in this project expands the tools available for in vivo study of the Dlk1-Dio3 ncRNA locus."]},{"key":"dc:title","label":"Title","values":["Optimization of adeno-associated virus production for misexpression of Dlk1-Dio3 noncoding RNAs in cardiac and skeletal muscle analysis in vivo"]}]}],"canonical_facts":{"dc:contributor.advisor":["Naya, Francisco J."],"dc:creator":["Sutton, Hannah Marie"],"dc:date.accessioned":["2024-09-26T14:56:31Z"],"dc:date.available":["2024-09-26T14:56:31Z"],"dc:date.issued":["2023"],"dc:date.updated":["2024-09-25T19:02:19Z"],"dc:description.abstract":["Efficient targeting of genes to either inhibit or increase their expression in specific tissues in vivo remains a challenge. Adeno-Associated Virus (AAV) has emerged as an efficacious delivery method in both humans and murine model systems. AAV is a non-enveloped, single-stranded DNA virus that is non-integrating with long-term expression. Due to its low immunogenicity and various serotypes with specific tissue tropisms, AAV is a preferred choice for organ specific-gene delivery in many experimental settings. This project focused on protocol optimization for high-volume production of AAV plasmids, improved transfection efficiency, and increased viral yield and purity to specifically target noncoding RNAs (ncRNAs) expressed from the imprinted Dlk1-Dio3 locus. Five AAV9 viruses were produced, each containing one of the following transgenes: 1) human Meg3 cDNA for overexpression of this long noncoding RNA, 2) Meg3-specific short hairpin RNA for knockdown analysis, 3) eGFP cDNA to demonstrate AAV9 tissue tropism, 4) Cas9 cDNA, and 5) gene-specific guide RNAs to target the Meg3 proximal promoter. The AAV9 virus production protocol optimized in this project expands the tools available for in vivo study of the Dlk1-Dio3 ncRNA locus."],"dc:identifier.uri":["https://hdl.handle.net/2144/49337"],"dc:language.iso":["en_US"],"dc:subject":["Molecular biology","Adeno-associated virus","Dlk1-Dio3 locus","Meg3","Noncoding RNA"],"dc:title":["Optimization of adeno-associated virus production for misexpression of Dlk1-Dio3 noncoding RNAs in cardiac and skeletal muscle analysis in vivo"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Molecular Biology, Cell Biology & Biochemistry"],"thesis:degree_level":["masters"],"thesis:degree_name":["M.A."],"thesis:institution_name":["Boston University"]},"updated_at":"2026-11-18T19:53:16Z"}